1-Bromo-5-fluoro-4-methoxy-2-methylbenzene, 98%, 1g

N,N'-Diisopropylcarbodiimide>98.0%(GC)250g

3-Cyclohexylisoxazol-5-amine, 95.0%, 1g

4-methyl-3-(pentanoylamino)benzoic acid, 95.0%, 250mg

(4-Isobutyl-piperazin-1-yl)-oxo-acetic acid, 98.0%, 1g

3-(1,1-Dimethylethyl)-1-[(4-fluorophenyl)methyl]-1H-pyrazole-5-carboxylic acid hydrazide, 250mg

(5-Fluoro-2-(methylcarbamoyl)phenyl)boronic acid, 95.0%, 100mg

6-(Difluoromethyl)-3-pyridinecarboxylic acid, 95.0%, 5g

3-[2-(3,4-dimethoxyphenyl)ethyl]-2-sulfanyl-3,4-dihydroquinazolin-4-one, 98%, 250mg

Sample beakers with screw closure with graduation and labelling area, 120 ml, Non-sterile, 500 Piece(s)

1-(4-Bromophenyl)ethane-1,2-diol, 95.0%, 1g

Gemcitabine, 95.0%, 1g

trans-1-Benzyl-4-(p-tolyl)pyrrolidine-3-carboxylic acid Hydrochloride, 95.0%, 250mg